Development of vaccines and biologics for infectious diseases
Official title: 1800009I ADVANCED BIOSCIENCE LABORATORIES, INC.; TO V4 PIPB--1 BASE TASK ORDER FUNDING; IID CAN 8470036 $173,773
Funded at Advanced Bioscience Laboratories, INC. · NIH-9952483 · Data updated 2026-11-12
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2019 |
| Award (this year) | $173,773 |
| NIH project number | 272201800009I-0-759301900131-1 |
| Project ID | NIH-9952483 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals at risk for infectious diseases, particularly those who may be eligible for vaccination.
✕Less likely to help
Patients who are not at risk for infectious diseases or those who have contraindications to vaccination may not receive benefit from this research.
What this research studies
This research focuses on the development and manufacturing of vaccines and biologics aimed at combating infectious diseases. It involves planning and optimizing products, ensuring compliance with good manufacturing practices (cGMP), and conducting clinical studies. The project includes technical audits and regulatory support to facilitate the submission of new vaccines to the U.S. Food and Drug Administration (FDA). Patients may benefit from the introduction of new vaccines that could protect against various infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines that significantly reduce the incidence of infectious diseases.
How similar studies have gone: Other research in vaccine development has shown significant success, indicating that this approach is both tested and promising.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Tmothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tmothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.